Evotec takes on GSK site

Pharmaceutical CDMO Evotec has acquired GlaxoSmithKline’s site at Verona, Italy, where its Aptuit subsidiary is already active, employing 750. Terms were not disclosed. Following a meeting with site workers, the company has also agreed to rename the site Campus Levi-Montalcini, in honour of the Italian Nobel laureate Rita Levi-Montalcini.

The Hamburg-based company said that Campus Levi-Montalcini will be integral to its growth over the next few years, as planned under its global strategic framework, Action Plan 2025. The existing buildings and the site as a whole both offer potential for further capacity expansions.

“The site comprises all technologies and services needed to develop a drug discovery project from the idea, through pre-clinical and clinical development, all the way to the market,” Evotec added. These include, Indigo, the interdisciplinary service for accelerated drug development, API manufacturing, pre-formulation and cGMP drug product manufacture.